Lori Eldean Hansen, MD | |
13313 N. Meridian, Suite A-3, Okla City, OK 73120 | |
(405) 753-9600 | |
(405) 753-9601 |
Full Name | Lori Eldean Hansen |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 13313 N. Meridian, Okla City, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447429972 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 13287 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lori Eldean Hansen, MD 13313 N. Meridian, Suite A-3, Okla City, OK 73120 Ph: (405) 753-9600 | Lori Eldean Hansen, MD 13313 N. Meridian, Suite A-3, Okla City, OK 73120 Ph: (405) 753-9600 |
News Archive
Since 2006, research has succeeded in generating, from specialised adult cells, induced pluripotent cells (iPS cells), with huge potential applications, particularly for regenerative medicine. However, the process has still not been completely mastered. Two teams of researchers from Inserm, CNRS, Centre Léon Bérard and Claude Bernard Lyon 1 University have discovered a molecule that may favour the production of these induced stem cells.
International Stem Cell Corporation, the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO's stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.
A new Harvard Medical School analysis shows that papers that present research on health conditions within sub-Saharan African countries in collaboration with wealthy or prestigious institutions or countries often fail to mention local researchers working on the same project, especially in prime positions such as first or senior author. The paper was published on October 18, 2019, in the journal BMJ Global Health.
Language in Facebook posts may help identify conditions such as diabetes, anxiety, depression and psychosis in patients, according to a study from Penn Medicine and Stony Brook University researchers.
In two articles, published in Circulation, researchers from the University of Pennsylvania School of Medicine provide further evidence for the role of cyclooxygenases (COX) in heart-disease risk.
› Verified 2 days ago